DXB 8.89% 49.0¢ dimerix limited

Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-17

  1. 1,982 Posts.
    lightbulb Created with Sketch. 434
    Looks like Novartis just posted their phase 2 results in IGA Nephropathy .... can they become interested?
    https://hotcopper.com.au/data/attachments/3251/3251834-b12a4420003b08bd75be68ce1ebfac0a.jpg
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.